Companies Cryptocurrencies
Harrow Health Inc
Harrow Health Inc
Exchange: NasdaqCM
IPO Date: 08/02/2013
CEO: Mr. Mark Baum
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • HROW
  • 9.49
  • 255223104
    market cap
  • 0.3000002
If you bought

shares of Harrow Health Inc (HROW) on
You would have made
Old Price $12 Current Price $12

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in San Diego, California and currently employs 134 full-time employees. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.

Address: 102 WOODMONT BLVD SUITE 610 Nashville TENNESSEE 92130

Stay updated.